Showing results (181-190 of 360) with videos related to

Sort By:
Pageof 36
Antibiotics (Basel, Switzerland)|November 11, 2022
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro EvidenceInmaculada Lopez-Montesinos, María Milagro Montero, Sandra Domene-Ochoa, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 1, 1995
[A case of Brunner's gland hamartoma as a cause of digestive tract hemorrhage]S Rojas Ortega, S Sánchez Sosa, G R San Román, et al.
Operative Dentistry|December 9, 2024
Dental Dam Isolation for Crown Removal, Atraumatic Tooth Extraction, Immediate Implant Placement, and Restoration Cementation: A Case StudyG Guzman-Perez, S Rojas-Rueda, F Floriani, et al.
Biochemical Pharmacology|December 15, 1990
Characterization of neuropathy target esterase using trifluoromethyl ketonesT C Thomas, A Székács, S Rojas, et al.
Bioorganic & Medicinal Chemistry|April 8, 2017
Synthesis of 4(3H)quinazolinimines with selective cytotoxic effect on human acute promyelocytic leukemia cellsAlexandra Becerra, Celso Quintero, Valeria Morales, et al.
Parasite Immunology|August 10, 2010
Protection against Naegleria fowleri infection in mice immunized with Cry1Ac plus amoebic lysates is dependent on the STAT6 Th2 responseM Carrasco-Yepez, S Rojas-Hernandez, M A Rodriguez-Monroy, et al.
Canadian Journal of Microbiology|June 13, 2001
IgA and IgM anti-Naegleria fowleri antibodies in human serum and salivaV Rivera, D Hernández, S Rojas, et al.
Open Forum Infectious Diseases|February 2, 2022
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A InfectionJeremy J Lim, Sadia Dar, Dirk Venter, et al.
Scientific Reports|March 4, 2017
Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriersT Hidalgo, M Giménez-Marqués, E Bellido, et al.
Scientific Reports|November 13, 2021
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection modelMaría M Montero, Sandra Domene-Ochoa, Carla López-Causapé, et al.
Pageof 36